WHO WE ARE

Every patient matters

Our pipeline contains novel therapies designed to address orphan conditions of the brain and nervous system in order to improve quality of life and patient outcomes.

We partner with these patients, their families and caregivers, and healthcare professionals to provide a comprehensive approach that goes beyond treating symptoms to ensure that patients’ experiences, perspectives, needs, and priorities are meaningfully incorporated into our work.

A History of Success

We back up our commitment with a leadership team that has extensive experience with global biotech companies and a proven track record of developing and commercializing treatments for orphan central nervous system (CNS) diseases.

The Noema Team

Luigi Costa

Chief Executive Officer

George Garibaldi, MD

Chief Medical Officer

Sally Nixon
Renata Lazarova, MD
Amine Tahiri
Simon Roitt
Simon Roitt

Smiljana Milosavljevic Ristic MD, PhD

BOARD OF DIRECTORS

Jeffrey Jonas, MD 

Chairman

Darren Carroll

Antoine Papiernik

Arthur Franken 

SCIENTIFIC Advisors

Stephen Stahl, MD, PhD

Gerald A. Maguire, MD

Terence Coderre, PhD

Tanjala T. Gipson, MD

Ali Mostajelean, MD

Andreas Hartmann, MD

Michael Doherty, MD